Announcing: The Leukemia & Lymphoma Society-Snowdome Foundation-Leukemia Foundation Translational Research Program 2019-2020
The Snowdome Foundation in partnership with Leukemia & Lymphoma Society and Leukaemia Foundation are launching several competitive Translational Research Program grants at $650,000 (USD) each.
The Leukemia & Lymphoma Society-Snowdome Foundation-Leukemia Foundation Translational Research Program grants are available to Australian Principal or Co-Principal Investigators with translational research ideas that will advance breakthroughs in blood cancer (myeloma, lymphoma and leukaemia) treatments. This year, a special focus will be given to one of the grants in the area of epigenetics research as the Victorian Epigenetics Group (VEG) are a major contributor to the Snowdome Foundation funding of this research grant.
Snowdome Foundation is proud to be offering these world-class research grants for the second year, demonstrating our commitment to cutting-edge blood cancer research.
Letter of intent to be received by August 31st 2019.
Visit www.LLS.org/research/translational-research-program for more information.
If you wish to be advised of Snowdome’s call for grants, email your contact details and area of interest to [email protected]